JP2004507251A5 - - Google Patents

Download PDF

Info

Publication number
JP2004507251A5
JP2004507251A5 JP2002522514A JP2002522514A JP2004507251A5 JP 2004507251 A5 JP2004507251 A5 JP 2004507251A5 JP 2002522514 A JP2002522514 A JP 2002522514A JP 2002522514 A JP2002522514 A JP 2002522514A JP 2004507251 A5 JP2004507251 A5 JP 2004507251A5
Authority
JP
Japan
Prior art keywords
expression
wnt
tumor
cells
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002522514A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004507251A (ja
Filing date
Publication date
Priority claimed from US09/759,056 external-priority patent/US7173115B2/en
Application filed filed Critical
Priority claimed from PCT/US2001/021635 external-priority patent/WO2002018608A2/en
Publication of JP2004507251A publication Critical patent/JP2004507251A/ja
Publication of JP2004507251A5 publication Critical patent/JP2004507251A5/ja
Pending legal-status Critical Current

Links

JP2002522514A 2000-08-29 2001-07-10 癌の治療効果を増強するための方法 Pending JP2004507251A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US22891400P 2000-08-29 2000-08-29
US09/759,056 US7173115B2 (en) 2000-01-13 2001-01-11 Stra6 polypeptides
PCT/US2001/021635 WO2002018608A2 (en) 2000-08-29 2001-07-10 Methods for enhancing the efficacy of cancer therapy
US09/901,812 US20020173461A1 (en) 2000-01-13 2001-07-10 Methods for enhancing the efficacy of cancer therapy

Publications (2)

Publication Number Publication Date
JP2004507251A JP2004507251A (ja) 2004-03-11
JP2004507251A5 true JP2004507251A5 (https=) 2008-10-02

Family

ID=27397886

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002522514A Pending JP2004507251A (ja) 2000-08-29 2001-07-10 癌の治療効果を増強するための方法

Country Status (10)

Country Link
EP (2) EP1341923A2 (https=)
JP (1) JP2004507251A (https=)
KR (1) KR20080068147A (https=)
AT (1) ATE453718T1 (https=)
AU (1) AU2001271938A1 (https=)
CA (1) CA2420867C (https=)
DE (1) DE60140966D1 (https=)
ES (1) ES2337696T3 (https=)
NZ (1) NZ524230A (https=)
WO (1) WO2002018608A2 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004519250A (ja) * 2000-03-23 2004-07-02 キュラゲン コーポレイション 新規ヒトstra6様タンパク質およびこれをコードする核酸
CA2481239A1 (en) * 2002-04-05 2003-10-23 University Of Utah Research Foundation Regulation of a novel colon specific retinol dehydrogenase by apc and cdx2
WO2003090686A2 (en) 2002-04-25 2003-11-06 University Of Connecticut Health Center Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
EP1833970A2 (en) * 2004-12-22 2007-09-19 Genentech, Inc. Methods for producing soluble multi-membrane-spanning proteins
TWI407971B (zh) * 2007-03-30 2013-09-11 日東電工股份有限公司 Cancer cells and tumor-related fibroblasts
SI2710035T1 (sl) 2011-05-16 2017-07-31 F. Hoffmann-La Roche Ag Agonisti FGFR1 in tehnike njihove uporabe
TWI728373B (zh) 2013-12-23 2021-05-21 美商建南德克公司 抗體及使用方法
CN114574378B (zh) * 2022-04-11 2023-09-22 浙江大学 一种生产视黄酸的基因工程菌及其构建方法和应用
CN117625626B (zh) * 2024-01-25 2024-04-16 中国农业科学院植物保护研究所 RNAi在提高苏云金芽胞杆菌杀虫蛋白防治二化螟或草地贪夜蛾效果中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4997852A (en) * 1987-08-26 1991-03-05 Ohio State University Research Foundation Method and composition for achieving cancer chemopreventive and chemotherapeutic activity
US5731167A (en) * 1992-01-17 1998-03-24 The United States Of America As Represented By The Department Of Health And Human Services Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy
AU2582897A (en) 1996-03-15 1997-10-01 Millennium Pharmaceuticals, Inc. Compositions and methods for the diagnosis, prevention, and treatment of neoplastic cell growth and proliferation
CA2397207C (en) * 2000-01-13 2013-12-03 Genentech, Inc. Novel stra6 polypeptides

Similar Documents

Publication Publication Date Title
KR100512819B1 (ko) 종양 치료용 조성물 및 방법
US8163476B2 (en) CUDR as biomarker for cancer progression and therapeutic response
Miyasaka et al. Analysis of differentially expressed genes in human hepatocellular carcinoma using suppression subtractive hybridization
JP2005522986A5 (https=)
CA2323093A1 (en) Compounds and methods for therapy and diagnosis of lung cancer
EP2424896A1 (en) Anti ceacam1 antibodies and methods of using same
US20030175900A1 (en) Compositions and methods for the treatment of tumor
KR20130135402A (ko) 종양에서 특이적으로 발현되는 유전 산물 및 그의 용도
EP2743697A2 (en) Methods and products for in vitro diagnosis, in vitro prognosis and the development of drugs against invasive carcinomas
JP2005027667A5 (https=)
JP2004507251A5 (https=)
US7429452B2 (en) Methods for diagnosis and therapy of pancreatic cancer and composition useful therein
KR20040073588A (ko) 종양 치료용 조성물 및 방법
JP2003521244A5 (https=)
CN101111768A (zh) 肺癌预后
CN104789689B (zh) 作为肺腺癌诊治靶标的clec9a基因
CN106701902B (zh) Foxr2基因和表达产物在肝癌诊断与治疗中的应用
CN108003239A (zh) 一种全人源抗egfr单链抗体及其应用
US8975030B2 (en) Method for cancer detection
KR20080068147A (ko) 암 치료의 효능을 증진시키는 방법
JP2009523004A5 (https=)
KR100865801B1 (ko) 암 치료의 효능을 증진시키는 방법
JP2012143242A (ja) 乳癌において差次的に発現される遺伝子
CN104001174B (zh) Ssx2ip在预防和治疗肿瘤转移中的应用
CN105112554B (zh) Clec1b基因在胆管癌诊断和治疗中的应用